1
|
Ducharme A. A Critical Appraisal of Beta-Blocker Therapy in Takotsubo Syndrome. JACC. HEART FAILURE 2025; 13:826-828. [PMID: 40335232 DOI: 10.1016/j.jchf.2025.02.012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/28/2025] [Accepted: 02/03/2025] [Indexed: 05/09/2025]
Affiliation(s)
- Anique Ducharme
- Department of Medicine, University of Montreal, and Heart Failure Clinic, Montreal Heart Institute Research Center, Montréal, Québec, Canada.
| |
Collapse
|
2
|
Mauriello A, Giudice CD, Vecchio GED, Correra A, Maratea AC, Grieco M, Amata A, Quagliariello V, Maurea N, Proietti R, Giordano A, D’Andrea A, Russo V. Takotsubo Syndrome and Oxidative Stress: Physiopathological Linkage and Future Perspectives. Antioxidants (Basel) 2025; 14:522. [PMID: 40427405 PMCID: PMC12108290 DOI: 10.3390/antiox14050522] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/07/2025] [Revised: 04/25/2025] [Accepted: 04/26/2025] [Indexed: 05/29/2025] Open
Abstract
Takotsubo syndrome (TTS) is an acute coronary syndrome of unknown prevalence with a physiopathological mechanism that is not yet fully understood. The course is generally benign. Current therapeutic management is based on limited evidence. Oxidative stress seems to play a role in the pathogenesis of cardiovascular diseases, especially regarding the endothelial dysfunction underlying TTS. The present review aims to describe the pathophysiological mechanisms linking oxidative stress and TTS, explore the impact of oxidative stress on TTS, and evaluate the efficacy of anti-oxidative stress therapies on TTS.
Collapse
Affiliation(s)
- Alfredo Mauriello
- S.C. Cardiologia, Istituto Nazionale Tumori, IRCCS, Fondazione “G. Pascale”, 80131 Naples, Italy; (A.M.); (A.C.M.); (V.Q.); (N.M.)
| | - Carmen Del Giudice
- Cardiology Unit, Boscotrecase Hospital, ASL NA3Sud, 81042 Boscotrecase, Italy;
| | | | - Adriana Correra
- Intensive Cardiac Care Unit, “San Giuseppe Moscati” Hospital, ASL CE, 81031 Aversa, Italy;
| | - Anna Chiara Maratea
- S.C. Cardiologia, Istituto Nazionale Tumori, IRCCS, Fondazione “G. Pascale”, 80131 Naples, Italy; (A.M.); (A.C.M.); (V.Q.); (N.M.)
| | - Martina Grieco
- Cardiology Unit, S. Giovanni Bosco Hospital, ASL NA1, 80100 Naples, Italy;
| | - Arianna Amata
- Department of Cardiovascular Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy;
| | - Vincenzo Quagliariello
- S.C. Cardiologia, Istituto Nazionale Tumori, IRCCS, Fondazione “G. Pascale”, 80131 Naples, Italy; (A.M.); (A.C.M.); (V.Q.); (N.M.)
| | - Nicola Maurea
- S.C. Cardiologia, Istituto Nazionale Tumori, IRCCS, Fondazione “G. Pascale”, 80131 Naples, Italy; (A.M.); (A.C.M.); (V.Q.); (N.M.)
| | - Riccardo Proietti
- Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart & Chest Hospital, Liverpool L8 7TX, UK;
| | - Antonio Giordano
- Sbarro Institute for Cancer Research and Molecular Medicine and Center of Biotechnology, College of Science and Technology, Temple University, BioLife Science Bldg, Suite 431-1900 N 12th Street, Philadelphia, PA 19122, USA;
| | - Antonello D’Andrea
- Cardiology and Intensive Care Unit, Department of Cardiology, “Umberto I” Hospital, 84014 Nocera Inferiore, Italy;
| | - Vincenzo Russo
- Cardiology Unit, Department of Medical and Translational Sciences, University of Campania “Luigi Vanvitelli”, Monaldi Hospital, 80131 Naples, Italy
| |
Collapse
|